Bank Of America Corp /De/ - Jul 26, 2011 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
10%+ Owner
Signature
BANK OF AMERICA CORP /DE/ Andres Ortiz By:Its: Authorized Signatory Andres Ortiz
Stock symbol
HCA
Transactions as of
Jul 26, 2011
Transactions value $
$8,392
Form type
4
Date filed
3/28/2025, 04:11 PM
Next filing
Dec 13, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Purchase $18.7K +670 $27.97 0 Jul 26, 2011 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Sale -$10.4K -477 -100% $21.90 0 Jan 10, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Purchase $11.1K +477 $23.29 0 Jan 13, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Sale -$2.66K -100 -100% $26.58 0 Jan 25, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Purchase $2.66K +100 $26.58 0 Jan 25, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Sale -$2.66K -100 -100% $26.58 0 Jan 25, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Purchase $2.66K +100 $26.58 0 Jan 25, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Sale -$2.66K -100 -100% $26.59 0 Jan 25, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Purchase $2.66K +100 $26.59 0 Jan 25, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Sale -$3.72K -148 -100% $25.15 0 Feb 1, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Purchase $3.69K +148 $24.91 0 Feb 2, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Purchase $26.30 +1 $26.27 0 Feb 3, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Purchase $928 +32 $29.00 0 Feb 7, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Purchase $27.80 +1 $27.78 0 Feb 13, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Sale -$805 -32 -100% $25.17 0 Feb 14, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Sale -$25 -1 -100% $25.10 0 Feb 14, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Sale -$25 -1 -100% $25.16 0 Feb 17, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Sale -$5.08K -200 -100% $25.41 0 Feb 22, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Purchase $5.09K +200 $25.46 0 Feb 22, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Purchase $39.9K +1.58K $25.28 0 Mar 8, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Sale -$2.02K -80 -100% $25.31 0 Mar 8, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Sale -$32.9K -1.3K -100% $25.31 0 Mar 8, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Sale -$2.53K -100 -100% $25.32 0 Mar 8, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Sale -$2.53K -100 -100% $25.32 0 Mar 8, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Purchase $51.30 +2 $25.63 0 Mar 9, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Sale -$51 -2 -100% $25.34 0 Mar 15, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Sale -$633 -25 -100% $25.33 0 Mar 16, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Purchase $630 +25 $25.18 0 Mar 19, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Sale -$3K -112 -100% $26.83 0 Apr 3, 2012 See Footnotes F1, F2, F3, F4
transaction HCA Common Stock Sale -$8.05K -300 -100% $26.83 0 Apr 3, 2012 See Footnotes F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Bank Of America Corp /De/ is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 This statement is jointly filed by Bank of America Corporation, Merrill Lynch, Pierce, Fenner & Smith Incorporated ("Merrill Lynch"), and Bank of America, N.A. ("BANA") (together, the "Reporting Persons"). Bank of America Corporation holds an indirect interest in the securities listed in this Report by virtue of its 100% ownership of its subsidiaries Merrill Lynch, and BANA. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any such Reporting Person is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Securities Exchange Act of 1934 (the "Exchange Act"), or for any other purpose.
F2 Each Reporting Person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) of the Exchange Act or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer or (ii) a member of any group with respect to the Issuer or any securities of the Issuer.
F3 Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer.
F4 The starting ownership position of the Reporting Persons is not reasonably available to the Reporting Persons and has accordingly been omitted pursuant to Rule 12b-21 under the Exchange Act.

Remarks:

Balance of trades included in attached schedule. (See Exhibit 99.1) Exhibit 99.2 - Joint Filing Agreement